Dose density and dose intensity: Where does CHOP go from here? Journal Article

  


Author: Portlock, C. S.
Article Title: Dose density and dose intensity: Where does CHOP go from here?
Keywords: adult; controlled study; human tissue; treatment outcome; survival analysis; human cell; prednisone; histopathology; neutropenia; doxorubicin; cancer combination chemotherapy; dose response; cancer radiotherapy; comparative study; rituximab; sensitivity and specificity; t lymphocyte; antineoplastic combined chemotherapy protocols; editorial; cyclophosphamide; vincristine; stem cell transplantation; dose-response relationship, drug; age; monoclonal antibody; prednisolone; cd20 antigen; cancer regression; lymphoma, non-hodgkin; lymphoma cell; lymphoma; outcomes research; maximum tolerated dose; growth factor; dose calculation; myeloablative agent; humans; prognosis; human; priority journal
Journal Title: Annals of Oncology
Volume: 13
Issue: 9
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2002-09-01
Start Page: 1329
End Page: 1330
Language: English
DOI: 10.1093/annonc/mdf238
PUBMED: 12196356
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-0036740489&partnerID=40&md5=bbb6cb1bf0d5ffca54594d43356775cf
Notes: Export Date: 14 November 2014 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    204 Portlock
Related MSK Work